Data from the medical literature suggest that surgical revascularisation is a safe intervention for paediatric MMS and most treated patients derive some symptomatic benefit. However, paucity of data on selection criteria and more global outcome measures means that the impact of surgical revascularisation on natural history remains uncertain. Direct and/or combined procedures provide better revascularisation, but this is not associated with differences in symptomatic outcome. International standardisation of the clinical approach to the treatment of paediatric MMS is urgently needed to critically evaluate the optimal indications for and timing of surgical revascularisation.

RIX4414 was efficacious, immunogenic and safe in the prevention of rotavirus gastroenteritis for at least two years post-vaccination in Hong Kong children.

HighlightsMesial temporal sclerosis (MTS) is a potential late complication of hematological malignancies.Seizures are usually drug resistant with MTS yet seizure freedom may be achieved by surgery.Early evaluation for epilepsy surgery is warranted for drug resistant seizures due to AML.

No abstract